SCHEMBL2370547

SCHEMBL2370547

COC(=O)[C@@H]1CC[C@H](NCc2ccccc2)C1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 3/20 0.48
ALDH1A1 P00352 3/20 0.48
HPGD P15428 2/20 0.48
MAPT P10636 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
HSD17B10 Q99714 1/20 0.48
GRIN2B Q13224 2/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
RAB9A P51151 1/20 0.46
OPRM1 P35372 2/20 0.46
OPRL1 P41146 2/20 0.46
BCHE P06276 2/20 0.45
ACHE P22303 2/20 0.45
LMNA P02545 1/20 0.45
PKM P14618 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
GAA P10253 1/20 0.45
TACR1 P25103 1/20 0.45
USP2 O75604 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2370551 1.00 LTA4H (0.48) LTA4HALDH1A1HPGDMAPTNPSR1
SCHEMBL2405273 0.93 ALDH1A1 (0.52) LTA4HALDH1A1HPGDMAPTNPSR1
SCHEMBL2405274 0.93 ALDH1A1 (0.52) LTA4HALDH1A1HPGDMAPTNPSR1
Ammonia Solution, Strong SCHEMBL3644104 0.91 ALDH1A1 (0.51) LTA4HALDH1A1HPGDMAPTNPSR1
SCHEMBL31629934 0.86 POLB (0.51) LTA4HMEN1KMT2ARAB9ABCHE
SCHEMBL2370430 0.84 LTA4H (0.62) LTA4HALDH1A1HPGDGRIN2BMEN1
SCHEMBL25635448 0.84 ALDH1A1 (0.47) ALDH1A1HPGDMAPTNPSR1HSD17B10
SCHEMBL13737148 0.83 CYP3A4 (0.44) ALDH1A1MAPTHSD17B10GRIN2BMEN1
SCHEMBL23948570 0.83 CYP1A2 (0.48) ALDH1A1HSD17B10GRIN2BMEN1KMT2A
Formic Acid SCHEMBL29049949 0.82 ALDH1A1 (0.43) LTA4HALDH1A1HPGDMAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150272947-A1 INHIBITORS OF PROTEIN KINASES ASTRAZENECA AB (SE) 2015-10-01 US disclosed
US-9067888-B2 Inhibitors of protein kinases ASTRAZENECA AB (SE) 2015-06-30 US disclosed
US-20130345233-A1 INHIBITORS OF PROTEIN KINASES INGENIUM PHARMACEUTICALS GMBH (DE) 2013-12-26 US disclosed
US-8518948-B2 Inhibitors of protein kinases INGENIUM PHARMACEUTICALS GMBH (DE) 2013-08-27 US disclosed
EP-2545037-A1 INHIBITORS OF PROTEIN KINASES Ingenium Pharmaceuticals GmbH (DE) 2013-01-16 EP disclosed
US-20110224225-A1 Inhibitors of protein kinases ASTRAZENECA AB (SE) 2011-09-15 US disclosed
WO-2011110612-A1 INHIBITORS OF PROTEIN KINASES INGENIUM PHARMACEUTICALS GMBH (DE) 2011-09-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130345233-A1 INHIBITORS OF PROTEIN KINASES CDK1, CDK2, CDK3 LTA4H 3474/4885ALDH1A1 2914/4885HPGD 2212/4885
US-20150272947-A1 INHIBITORS OF PROTEIN KINASES CDK1, CDK2, CDK3 LTA4H 3474/4885ALDH1A1 2914/4885HPGD 2212/4885
US-20110224225-A1 Inhibitors of protein kinases CDK1, CDK2, CDK3 LTA4H 3474/4885ALDH1A1 2914/4885HPGD 2212/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.